0
Pharmacogenetics of Psychotropic Drug Response
Anil K. Malhotra, M.D.; Greer M. Murphy, Jr., M.D., Ph.D.; James L. Kennedy, M.D.
Proxy and Surrogate Consent in Geriatric Neuropsychiatric Research: Update and Recommendations
Scott Y.H. Kim, M.D., Ph.D.; Paul S. Appelbaum, M.D.; Dilip V. Jeste, M.D.; Jason T. Olin, Ph.D.
A PET Study of Dopamine D2 and Serotonin 5-HT2 Receptor Occupancy in Patients With Schizophrenia Treated With Therapeutic Doses of Ziprasidone
David Mamo, M.D., M.Sc., F.R.C.P.(C); Shitij Kapur, M.D., Ph.D., F.R.C.P.(C); C. M. Shammi, M.D., F.R.C.P.(C); George Papatheodorou, M.D., F.R.C.P.(C); Steve Mann, B.A.; François Therrien, Pharm.D.; Gary Remington, M.D., Ph.D., F.R.C.P.(C)
Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study
Jeffrey H. Meyer, M.D., Ph.D.; Alan A. Wilson, Ph.D.; Sandra Sagrati, M.Ed.; Doug Hussey, B.Sc.; Anna Carella, B.Sc.; William Z. Potter, M.D.; Nathalie Ginovart, Ph.D.; Edgar P. Spencer, Ph.D.; Andy Cheok, M.D.; Sylvain Houle, M.D., Ph.D.
A Randomized, Placebo-Controlled Trial of Sertraline for Prophylactic Treatment of Highly Recurrent Major Depressive Disorder
Jean-Pierre Lépine, M.D.; Vincent Caillard, M.D.; Jean-Claude Bisserbe, M.D.; Sylvie Troy, M.D.; Jean-Michel Hotton, M.D.; Patrice Boyer, M.D.
Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy-Confirmed Dementia With Lewy Bodies
Clive G. Ballard, M.R.C.Psych., M.D.; Robin Jacoby, F.R.C.Psych., D.M.; Teodoro Del Ser, M.D.; M. Nadeem Khan, Ph.D.; David G. Munoz, M.D., F.R.C.P.(C), F.R.C.Path.; Clive Holmes, M.R.C.Psych., Ph.D.; Zsuzanna Nagy, M.D., D.Phil.; Elaine K. Perry, Ph.D.; Catherine Joachim, M.D.; Evelyn Jaros, Ph.D.; John T. O’Brien, F.R.C.Psych., D.M.; Robert H. Perry, F.R.C.Path.; Ian G. McKeith, F.R.C.Psych., M.D.
Sustained Benefit of Supportive Intervention for Depressive Symptoms in Caregivers of Patients With Alzheimer’s Disease
Mary S. Mittelman, Dr.P.H.; David L. Roth, Ph.D.; David W. Coon, Ph.D.; William E. Haley, Ph.D.
Extent and Cost of Informal Caregiving for Older Americans With Symptoms of Depression
Kenneth M. Langa, M.D., Ph.D.; Marcia A. Valenstein, M.D.; A. Mark Fendrick, M.D.; Mohammed U. Kabeto, M.S.; Sandeep Vijan, M.D., M.S.
Racial Differences in Paranoid Ideation and Psychoses in an Older Urban Population
Carl I. Cohen, M.D.; Carol Magai, Ph.D.; Robert Yaffee, Ph.D.; Lorna Walcott-Brown, M.S.
Selective Attention in Schizophrenia: Sparing and Loss of Executive Control
Daniel H. Mathalon, Ph.D., M.D.; Theda Heinks, Dipl.Psych.; Judith M. Ford, Ph.D.
Glial Cell Loss in the Anterior Cingulate Cortex, a Subregion of the Prefrontal Cortex, in Subjects With Schizophrenia
Anette K. Stark, M.D.; Harry B.M. Uylings, Prof., M.D., Ph.D.; Ernesto Sanz-Arigita, M.D., Ph.D.; Bente Pakkenberg, M.D., Dr.Med.Sci.
Elevated Maternal Interleukin-8 Levels and Risk of Schizophrenia in Adult Offspring
Alan S. Brown, M.D.; Jonathan Hooton, Ph.D.; Catherine A. Schaefer, Ph.D.; Haiying Zhang, Ph.D.; Eva Petkova, Ph.D.; Vicki Babulas, M.P.H.; Megan Perrin, B.S.; Jack M. Gorman, M.D.; Ezra S. Susser, M.D., Dr.P.H.
Abnormalities of Thalamic Volume and Shape in Schizophrenia
John G. Csernansky, M.D.; Mathew K. Schindler; N. Reagan Splinter; Lei Wang, Ph.D.; Mohktar Gado, M.D.; Lynn D. Selemon, Ph.D.; Devna Rastogi-Cruz, M.D.; Joel A. Posener, M.D.; Paul A. Thompson, Ph.D.; Michael I. Miller, Ph.D.
Risk for Cancer in Parents of Patients With Schizophrenia
Susanne Oksbjerg Dalton, M.D., Ph.D.; Thomas Munk Laursen, M.Sci.; Lene Mellemkjær, M.Sci., Ph.D.; Christoffer Johansen, M.D., Ph.D.; Preben Bo Mortensen, M.D., Dr.Med.Sci.
Depression and HIV Risk Behaviors Among Patients in a Sexually Transmitted Disease Clinic
Heidi E. Hutton, Ph.D.; Constantine G. Lyketsos, M.D., M.P.H.; Jonathan M. Zenilman, M.D.; Richard E. Thompson, Ph.D.; Emily J. Erbelding, M.D., M.P.H.
Early-Stage Face Processing Dysfunction in Patients With Schizophrenia
Martin J. Herrmann, Ph.D.; Heiner Ellgring, Dr. rer. nat.; Andreas J. Fallgatter, M.D.
Growth and Sexual Maturation During Long-Term Treatment With Risperidone
Fiona Dunbar, M.B., B.Ch.; Vivek Kusumakar, M.D.; Denis Daneman, M.B., B.Ch., F.R.C.P.C.; Miklos Schulz, Ph.D.
Obstetric Adversity and Age at First Presentation With Schizophrenia: Evidence of a Dose-Response Relationship
Brendan D. Kelly, M.R.C.Psych.; Larkin Feeney, M.R.C.P.I.; Eadbhard O’Callaghan, F.R.C.Psych.; Roy Browne, M.R.C.Psych.; Majella Byrne, Ph.D.; Niamh Mulryan, M.R.C.Psych.; Ann Scully, M.R.C.Psych.; Mary Morris, B.Sc.; Anthony Kinsella, M.Sc.; Noriyoshi Takei, Ph.D.; Thomas McNeil, Ph.D.; Dermot Walsh, F.R.C.P.I.; Conall Larkin, F.R.C.Psych.
Characteristics of Functional Auditory Hallucinations
MICHAEL D. HUNTER, M.R.C.Psych.; PETER W.R. WOODRUFF, Ph.D., M.R.C.P., M.R.C.Psych.
Hepatotoxicity Related to Citalopram
ENRIQUE LÓPEZ-TORRES, M.D.; M. ISABEL LUCENA, M.D., Ph.D.; JULIA SEOANE, M.D.; CARMEN VERGE, M.D.; RAÚL J. ANDRADE, M.D., Ph.D.
Clozapine With Amisulpride for Refractory Schizophrenia
MARCUS W. AGELINK, M.D.; ILKER KAVUK, M.D.; ISMAIL AK, M.D.
Is Multiple Cavernoma a Developmental Defect in Schizophrenia?
DAVID ISRAELI, M.D.; JOSEPH ZOHAR, M.D.
Antidepressants and Premature Labor
KEERTHY SUNDER, M.D., M.S., D.R.C.O.G.; KATHERINE L. WISNER, M.D., M.S.
Dr. Simon and Colleagues Reply
GREGORY E. SIMON, M.D., M.P.H.; ROBERT L. DAVIS, M.D., M.P.H.; MICHAEL L. CUNNINGHAM, M.D., Ph.D.
Body Dysmorphic Disorder and Art Background
KATHARINE A. PHILLIPS, M.D.; WILLIAM MENARD, B.A.
Dr. Shea Replies
M. TRACIE SHEA, Ph.D.
Drs. Hoffman and Cavus Reply
RALPH E. HOFFMAN, M.D.; IDIL CAVUS, M.D., Ph.D.
Transcranial Magnetic Stimulation and Processing of Facial Threats
JACK van HONK, Ph.D.; DENNIS J.L.G. SCHUTTER, M.A.
Dr. Stein Replies
MICHAEL D. STEIN, M.D.
Checklist Psychiatry’s Effect on Psychiatric Education
OLIVER FREUDENREICH, M.D.; JOHN QUERQUES, M.D.; NICHOLAS KONTOS, M.D.
Dr. Serby Replies
MICHAEL SERBY, M.D.
Dr. Brook and Colleagues Reply
DAVID W. BROOK, M.D.; JUDITH S. BROOK, Ed.D.; ZOHN ROSEN, M.S.; MARIO De la ROSA, Ph.D.; IVAN D. MONTOYA, M.D., M.P.H.; MARTIN WHITEMAN, Ph.D.
Dr. Lohr Replies
JAMES B. LOHR, M.D.
Violent Behavior Among Colombian Adolescents
MICHAEL G. VAUGHN, M.A., M.A.L.S.
Dr. Olfson and Colleagues Reply
MARK OLFSON, M.D., M.P.H.; MARC J. GAMEROFF, Ph.D.; PETER S. JENSEN, M.D.; STEVEN C. MARCUS, Ph.D.
Ethnic Differences in ADHD and the Mad/Bad Debate
ROB EVANS, M.B., Ch.B., M.R.C.Psych.
Dr. Klin Replies
AMI KLIN, Ph.D.
Comorbidity of Gender Identity Disorders
E.J. GILTAY, M.D., Ph.D.; L.J.G. GOOREN, M.D., Ph.D.; P.T. COHEN-KETTENIS, Ph.D.; A.D. BOENINK, M.D.; A.M. EECKHOUT, M.D.; H.M. HELLER, M.D.
Drs. à Campo and Nijman Reply
JOOST à CAMPO, M.D.; HENK NIJMAN, Ph.D.
Pater Familias
William Houghton, M.D.